Rede D'Or Sao Luiz S.A. Stocks

R$ 38.97Last Updated 31.03.2026

Issuer Rating

6/7
Performance

Favourable

Risk

Low

Recommendation

Buy

Market Cap

R$ 15.91B

Buy
Review
Evaluation
Target price
Dynamics
Performance
Growth
Dividends
Risks
R$ 38.97
Key Takeaways

Risk factor

Strong & resilient to price shocks

Data is available to registered users only
Data is available to registered users only

Profitability factor

Good growth

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Rede D'Or São Luiz S.A. operates a network of hospitals in Brazil. The company provides services in the medical areas of neurology, oncology, hemangioma, lymphangioma, lymphatic malformation, vascular anomaly and tumor, vascular surgery, radiology, interventional radiology, and pathology, as well as pediatric cardiology, oncology and hematology, and surgery. It operates 51 own hospitals, 1 managed hospital, and 47 oncology clinics with 9,000 beds, as well as provides other services, such as blood bank, dialysis, and ambulatories of various specialties in the states of Rio de Janeiro, São Paulo, Pernambuco, Bahia, Maranhão, Sergipe, Ceará, Paraná, and the Federal District; and has a robot surgery facilities in Brazil. The company was formerly known as Hospital Maternidade São Luiz S.A. Rede D'Or São Luiz S.A. was founded in 1977 and is headquartered in São Paulo, Brazil.

Company Valuation

Fairly valued
4/7

Based on key historical and expected multiples, the stock is fairly valued relative to its peers. Specifically, the stock is fairly valued on P/E, neutral on EV/EBITDA, o

Data is available to registered users only
Sign up to access detailed valuation

Target Price

Neutral
4/7

The average target price of RDOR3.SA is 41 and suggests 4% upside potential. Usually, this means a HOLD recommendation among investment firms. This neutral recommendation

Data is available to registered users only
Sign up to access analyst forecasts

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis
X-channel

Buy

Sell

0 more stocks